David Raiser and Iain MacLeod, Harvard University (IMAGE)
Caption
Harvard-trained scientists David Raiser and Iain MacLeod are cofounders of Aldatu Biosciences. The startup has licensed a novel qPCR genotyping platform developed at Harvard University that may help clinicians treating HIV to more quickly determine the most effective medication for each patient.
Credit
Photo courtesy of David Raiser.
Usage Restrictions
Editorial use only, in connection with this announcement.
License
Licensed content